Daiichi Pharmaceutical Co., Ltd.

Yoshiyuki Takasu

Eiichi Otomo

Kazuo Hasegawa

Tadashi Shiotani

Akira Honma

A method for aiding cerebral recovery following neurodegeneration, particularly after a stroke, in a mammal, by administration of nefiracetam is disclosed. This method of treatment allows an improvement in the recovery from stroke.

Method for aiding cerebral recovery following neurodegeneration

A method for improving the disturbancies of Activities of Daily Living in post-stroke patients by early administration of nefiracetam after the stroke is disclosed. This method of treatment allows an improvement in the recovery from stroke.

Method for improving disturbancies of activities of daily living after stroke

The present invention aims at providing a drug which is highly effective in improving decline of mental functions such as disorientation, which are the major symptoms of dementia such as Alzheimer type dementia or cerebrovascular dementia, as well as general side symptoms such as decreased spontaneity, contact disturbances, motivation, emotional disturbances, abnormal behaviors and disturbances in activity of daily living. The agent for improving dementia of the present invention comprises N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide or a salt thereof as an active ingredient.

Growing community of inventors

Tokyo, Japan

Yoshiyuki Takasu